Close Menu
Tennis Info
  • Home
  • News
  • Women Tennis
  • Match Previews
Facebook X (Twitter) Instagram
Trending
  • Thrilling Showdowns Ahead: Draper Takes on Fonseca and Fearnley Faces Norrie in French Open Round 3!
  • Exciting Additions: Tennis Welcomes Two New Stars for the 2025-26 Season!
  • Craig Kirchgessner Steps Down as Head Men’s Tennis Coach: A New Chapter Begins
  • Farewell to Women’s Tennis: A Journey of Growth and Passion
  • USC Men’s Tennis Delivers Thrilling 4-3 Upset Against UCLA!
  • Swiatek Triumphs in Thrilling Roland Garros Opener Against Sramkova
  • French Open R2 previews and predictions: Draper vs. Monfils, Cobolli vs. Arnaldi
  • Meet the Stars: 2025 ITA Division I Women’s Tennis All-Americans!
Tennis InfoTennis Info
  • Home
  • News
  • Women Tennis
  • Match Previews
Tennis Info
Home»News»Polish pharma firm points assertion after backlash over Iga Swiatek doping information
News November 30, 2024

Polish pharma firm points assertion after backlash over Iga Swiatek doping information

Polish pharma firm points assertion after backlash over Iga Swiatek doping information
Share
Facebook Twitter LinkedIn Pinterest Email Tumblr Reddit Telegram WhatsApp Copy Link

Polish pharmaceutical firm LEK-AM says there are “saddened” to listen to what occurred after Iga Swiatek consumed considered one of their manufactured drugs but additionally denied that they failed to answer the ITIA when contacted. 

After provisionally being suspended and later allowed to return to motion after figuring out the supply of contamination, Swiatek’s one-month ban began on November 27 – however the Pole solely had eight extra days to serve since she served 22 throughout her provisional suspension. 

In her message, the Polish tennis famous person stated it was “the toughest battle of her life” and one thing that left her feeling very anxious and gave sleepless nights.

Since she has been one of many prime and most profitable Polish athletes for a few years now, the corporate that manufactured the remedy obtained sure criticism and backlash in Poland.

“Like the international public opinion and fans of Ms. Iga Swiatek, we are saddened by the situation that has befallen the best tennis player in the world. We are deeply moved by Ms. Iga Świątek’s statement of November 28, 2024, not only as employees of a pharmaceutical company, but also as fans of Polish sports. We declare full cooperation in order to clarify any doubts,” Przedsiębiorstwo Farmaceutyczne LEK-AM stated in an announcement. 

Iga Swiatek© Polski Zwiazek Tenisowy/Instagram – Honest Use

 

LEK-AM denies that they did not reply to the ITIA

“ITIA did not contact us directly. We were contacted by a law firm from Great Britain, which did not indicate who it worked for. The law firm’s representative expected us to take actions that violated Polish pharmaceutical law (Art. 36 g sec. 1 item 10 of the Pharmaceutical Law Act, Journal of Laws 2024, item 686), especially in terms of sending medicines to unauthorized persons. This aroused our distrust and our lack of reaction to the initiated contact. From today’s perspective, we would have made contact,” the assertion continued.

Additionally, the corporate claimed that the remedy in query obtained nothing however very optimistic evaluations previously.

“We are sorry that the incident involved the drug Melatonina LEK-AM 1 mg – especially since our drug has enjoyed the recognition and trust of doctors and patients, including professional athletes, for many years. We meet all the highest standards of drug production. We follow all procedures related to the production of medicines,” they added. 

What the ITIA and Swiatek stated?

After the four-time French Open champion and her workforce decided from the place TMZ got here, they pleaded their protection to the ITIA. And after trying on the proof, the company accepted that the previous world No. 1 did not knowingly or deliberately take one thing that was on the prohibited checklist. 

“The ITIA accepted that the positive test was caused by the contamination of a regulated non-prescription medication (melatonin), manufactured and sold in Poland that the player had been taking for jet lag and sleep issues, and that the violation was therefore not intentional. This followed interviews with the player and their entourage, investigations, and analysis from two WADA-accredited laboratories,” the ITIA stated.

“In relation to the player’s level of fault, as the contaminated product was a regulated non-prescription medication in the player’s country of origin and purchase and considering all the circumstances of its use (and other contaminated product cases under the World Anti-Doping Code), the player’s level of fault was considered to be at the lowest end of the range for ‘No Significant Fault or Negligence.'”

In the meantime, Swiatek was fairly open in her message, saying it was probably the most tough factor she ever confronted and admitted that she “cried” loads throughout all the interval. Additionally, she confessed that she was feeling some main stress and anxiousness as a result of she did not know what was going to occur together with her profession.

Iga Swiatek Iga Swiatek© Polski Zwiazek Tenisowy/Instagram – Honest Use

 

Finally, all of it labored out effective for the world No. 2, who will be capable to begin the 2025 season in time.

In late December, the United Cup will mark the beginning of the brand new season and the 23-year-old is slated to symbolize Poland there. After the United Cup, the Pole ought to compete on the Australian Open. 

backlash company doping Iga issues NEWS pharma Polish statement Swiatek
Previous ArticleWhat to anticipate from Novak Djokovic and Andy Murray’s partnership
Next Article All levels of Jannik Sinner’s trial revealed

Related Posts

Craig Kirchgessner Steps Down as Head Men’s Tennis Coach: A New Chapter Begins

Craig Kirchgessner Steps Down as Head Men’s Tennis Coach: A New Chapter Begins

June 1, 2025
USC Men’s Tennis Delivers Thrilling 4-3 Upset Against UCLA!

USC Men’s Tennis Delivers Thrilling 4-3 Upset Against UCLA!

May 31, 2025
Former Duke Tennis Star Challenges NCAA Settlement, Claims False NIL Promises and Retaliation

Former Duke Tennis Star Challenges NCAA Settlement, Claims False NIL Promises and Retaliation

May 31, 2025
Unveiling the Top Contenders: February 20 Division I Men’s Collegiate Tennis Rankings!

Unveiling the Top Contenders: February 20 Division I Men’s Collegiate Tennis Rankings!

May 31, 2025
Add A Comment
Leave A Reply Cancel Reply


Categories
Archives
June 2025
MTWTFSS
 1
2345678
9101112131415
16171819202122
23242526272829
30 
« May    
Tennis Info
  • About Us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
© 2025 Tennis Info. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.